Pfizer is investing an additional half billion dollars in the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, NC. This facility is anticipated to support Pfizer’s continuing investment in gene therapy research and development, similar to Pfizer’s Chapel Hill and Kit Creek, NC research and development sites. This facility would expand the company’s presence in North Carolina, where there are currently more than 3,600 Pfizer colleagues, including 650 in Sanford...